RBC Capital Markets Podcasts

Insights

Cidara’s pursuit of universal flu protection with a single dose

CEO Jeff Stein discusses Cidara Therapeutics mission and their promising antiviral that could become a new alternative...

Insights

Energy security is reshaping sustainable investing

Amid headwinds, sustainable investing shifts focus – targeted climate funds, nuclear energy and grid resilience lead...

Insights

Mid-year market musings

In this episode we review the bull thesis that we heard in our investor meetings as 2Q came to a close.

Insights

Ocular Therapeutix’ bold vision to redefine retinal disease treatment

Pravin Dugel, CEO of Ocular Therapeutix, shares insights on retinal disease treatments, challenges, opportunities, and...

Insights

Building a capital strategy to support decarbonization at scale

As both an oil and gas producer and a carbon capture leader, California Resources Corporation is positioning itself at...

Insights

Mid-year 2025 global analyst outlook survey

In today’s podcast we discuss how our analysts are constructive on performance over the next 6-12 months.

Insights

PTC Therapeutics: Building a durable company to benefit patients

In its 25-year history, PTC Therapeutics has expanded its range and found ways to speed up drug development, CEO Matt...

Insights

Tamboran’s strategy to unlock Australia’s natural gas potential

As Australia's unconventional gas sector transitions from exploration to commercial production, Tamboran Resources is...

Insights

Recapping our Middle East read throughs

How we’re thinking about the recent developments in the Middle East from a US equity market perspective.